Cargando…

The use of direct acting oral anticoagulants in patients with COVID-19 infection

The use of direct-acting oral anticoagulants (DOACs) has increased rapidly in the last decade; becoming the mainstay for both the prophylaxis and the treatment of venous thromboembolism in various situations including non-valvular atrial fibrillation, joint replacement surgeries and acute DVT/PE, et...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aly, Ragia, Gupta, Sachin, Singh, Balraj, Kaur, Parminder, Kim, Kunhwa, Gupta, Sorab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043519/ https://www.ncbi.nlm.nih.gov/pubmed/33889317 http://dx.doi.org/10.1080/20009666.2020.1867295

Ejemplares similares

Case Report: Heparin-induced thrombocytopenia in a patient with COVID-19
por: Aly, Ragia, et al.
Publicado: (2021)

Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review
por: Gupta, Sachin, et al.
Publicado: (2021)

COVID-19 Infection and Arterial Thrombosis: Report of Three Cases
por: Singh, Balraj, et al.
Publicado: (2021)

Primary Gastric Adenosquamous Carcinoma: A Case Report
por: Aly, Ragia, et al.
Publicado: (2020)

Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors
por: Aly, Ragia, et al.
Publicado: (2020)

Covid-19 Presenting as Acute Limb Ischemia
por: Singh, Balraj, et al.
Publicado: (2020)

Incidental early diagnosis of biphasic pulmonary blastoma in a patient with history of stage IV lung adenocarcinoma
por: Kim, Kunhwa, et al.
Publicado: (2020)

A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer
por: Gupta, Sachin, et al.
Publicado: (2021)

An Unusual Initial Presentation of Diffuse Large B-Cell Lymphoma as Recurrent Syncope
por: Kim, Kunhwa, et al.
Publicado: (2019)

Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer
por: Singh, Balraj, et al.
Publicado: (2021)

COVID-19 and acute mesenteric ischemia: A review of literature
por: Singh, Balraj, et al.
Publicado: (2021)

Direct-acting Oral Anticoagulants: An Overview
por: Salem, Hatem H.
Publicado: (2017)

The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Extrapulmonary Small Cell Carcinoma
por: Aly, Ragia, et al.
Publicado: (2020)

Mycobacterial Spindle Cell Pseudotumor of the Lymph Nodes
por: Singh, Balraj, et al.
Publicado: (2021)

Splanchnic vein thrombosis in COVID-19: A review of literature
por: Singh, Balraj, et al.
Publicado: (2020)

COVID-19 and Influenza Co-Infection: Report of Three Cases
por: Singh, Balraj, et al.
Publicado: (2020)

Distinct pleiotropic effects of direct oral anticoagulants on cultured endothelial cells: a comprehensive review
por: Atzemian, Natalia, et al.
Publicado: (2023)

Rhabdomyolysis in COVID-19: Report of Four Cases
por: Singh, Balraj, et al.
Publicado: (2020)

Pancreatic cancer presenting with pulmonary cannonball lesions
por: Singh, Balraj, et al.
Publicado: (2021)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

Medications that interact with direct-acting oral anticoagulant exposure
por: de Vries, T. A. C., et al.
Publicado: (2021)

COVID-19 vaccine induced Axillary and Pectoral Lymphadenopathy on PET scan
por: Singh, Balraj, et al.
Publicado: (2021)

Hepatocellular Carcinoma Presenting With Inferior Vena Cava Tumor Thrombus Extending to the Right Atrium: A Case Report
por: Aly, Ragia, et al.
Publicado: (2020)

Acute myocardial infraction and pulmonary embolism in a same patient with COVID -19: a rare association
por: Randhawa, Preet, et al.
Publicado: (2021)

COVID-19 and Diabetic Ketoacidosis: Report of Eight Cases
por: Singh, Balraj, et al.
Publicado: (2021)

COVID-19 and bleeding at unusual locations: Report of four cases
por: Singh, Balraj, et al.
Publicado: (2021)

COVID-19 and thrombotic thrombocytopenic purpura: A review of literature
por: Singh, Balraj, et al.
Publicado: (2021)

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
por: Gao, Lulu, et al.
Publicado: (2017)

Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome
por: Sexton, Donal J., et al.
Publicado: (2018)

Direct-Acting Oral Anticoagulants: Practical Considerations for Emergency Medicine Physicians
por: Peacock, W. Frank, et al.
Publicado: (2016)

Adding Herbal Products to Direct-Acting Oral Anticoagulants Can Be Fatal
por: Maadarani, Ossama, et al.
Publicado: (2019)

Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
por: Doucette, Kimberley, et al.
Publicado: (2020)

Direct-Acting Oral Anticoagulant Therapy in Cancer Patients—A Review
por: Górnicki, Tomasz, et al.
Publicado: (2023)

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
por: Rose, Adam J., et al.
Publicado: (2021)

Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
por: Abdelnabi, Mahmoud, et al.
Publicado: (2022)

The efficacy and safety of out-hospital anticoagulation therapy with direct oral anticoagulant for COVID-19
por: Geng, Yu, et al.
Publicado: (2023)

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2021)

COVID–19 and arterial thrombosis: Report of 2 cases
por: Singh, Balraj, et al.
Publicado: (2021)

Direct oral anticoagulant use in left ventricular thrombus
por: Ali, Zafar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r9beufoq1hf2eu8ufpq0tm1t1l